Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 21% ± 5% | |
| plasma cell | 4 studies | 24% ± 11% | |
| epithelial cell | 4 studies | 31% ± 12% | |
| fibroblast | 4 studies | 23% ± 7% | |
| pericyte | 3 studies | 18% ± 4% | |
| smooth muscle cell | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 25% ± 5% | |
| goblet cell | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5426.23 | 1445 / 1445 | 100% | 67.70 | 183 / 183 |
| liver | 100% | 4563.41 | 226 / 226 | 100% | 57.82 | 406 / 406 |
| ovary | 100% | 6448.55 | 180 / 180 | 100% | 77.67 | 430 / 430 |
| pancreas | 100% | 3712.75 | 328 / 328 | 100% | 68.40 | 178 / 178 |
| skin | 100% | 5507.03 | 1809 / 1809 | 100% | 98.65 | 472 / 472 |
| thymus | 100% | 6585.27 | 653 / 653 | 100% | 86.91 | 605 / 605 |
| uterus | 100% | 6246.53 | 170 / 170 | 100% | 75.83 | 459 / 459 |
| prostate | 100% | 6160.43 | 245 / 245 | 100% | 106.17 | 501 / 502 |
| kidney | 100% | 4640.48 | 89 / 89 | 100% | 64.01 | 899 / 901 |
| brain | 100% | 4410.63 | 2636 / 2642 | 100% | 70.26 | 705 / 705 |
| lung | 100% | 5560.98 | 578 / 578 | 100% | 74.25 | 1152 / 1155 |
| adrenal gland | 100% | 7549.60 | 258 / 258 | 100% | 72.95 | 229 / 230 |
| intestine | 100% | 5315.57 | 966 / 966 | 99% | 62.70 | 524 / 527 |
| stomach | 100% | 4595.03 | 359 / 359 | 99% | 60.74 | 284 / 286 |
| breast | 100% | 5355.89 | 459 / 459 | 99% | 78.71 | 1109 / 1118 |
| bladder | 100% | 5935.81 | 21 / 21 | 99% | 73.79 | 497 / 504 |
| adipose | 100% | 5340.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6244.91 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 98.63 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 71.54 | 29 / 29 |
| muscle | 100% | 7238.23 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5702.62 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 65.49 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 92.20 | 1 / 1 |
| heart | 99% | 4020.84 | 851 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 4324.01 | 918 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008104 | Biological process | protein localization |
| GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO_0006954 | Biological process | inflammatory response |
| GO_0021522 | Biological process | spinal cord motor neuron differentiation |
| GO_0048666 | Biological process | neuron development |
| GO_0005813 | Cellular component | centrosome |
| GO_0005801 | Cellular component | cis-Golgi network |
| GO_0030126 | Cellular component | COPI vesicle coat |
| GO_0005829 | Cellular component | cytosol |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0004713 | Molecular function | protein tyrosine kinase activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | SCYL1 |
| Protein name | N-terminal kinase-like protein (SCY1-like protein 1) N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase) SCY1 like pseudokinase 1 |
| Synonyms | GKLP TRAP HT019 NTKL TEIF CVAK90 TAPK |
| Description | FUNCTION: Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum . Involved in the maintenance of the Golgi apparatus morphology . Has no detectable kinase activity in vitro . .; FUNCTION: Isoform 6 acts as a transcriptional activator. It binds to three different types of GC-rich DNA binding sites (box-A, -B and -C) in the beta-polymerase promoter region. It also binds to the TERT promoter region. . |
| Accessions | Q96KG9 H0YCI6 E9PPN3 ENST00000528545.1 ENST00000420247.6 [Q96KG9-2] ENST00000524944.5 ENST00000270176.10 [Q96KG9-1] ENST00000527009.5 E9PS17 ENST00000525364.5 E9PK59 ENST00000531601.1 H0YDH0 ENST00000533862.5 [Q96KG9-6] |